MONDRAGON and i+Med Establish NanoSPharm to Innovate in Biomedical Sector through Cooperative Partnership.
Oct 03, 2026
Contract Type
partnership
Autonomous Community Of The Basque CountryNon Profit
Description
MONDRAGON and i+Med have launched NanoSPharm, a new biomedical company formed through a cooperative partnership, each owning a 50% stake. The initiative starts with an investment of €8.3 million and aims to market a technology that enhances the biocompatibility of prostheses.
Company Information
Company
MONDRAGON
Location
Autonomous Community Of The Basque Country, Spain
About
MONDRAGON is a cooperative enterprise that focuses on innovative and sustainable business practices. It aims to promote future-oriented business activities in high-value-added sectors. MONDRAGON is involved in various industries and emphasizes the significance of cooperation. The organization is committed to fostering economic and social value through collaborative projects.